Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus

NCT02702011 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: empagliflozin medium dose
DRUG: empagliflozin low dose
DRUG: empagliflozin high dose
DRUG: placebo

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]